Suglat Tablets are discovered through a research collaboration and is being jointly developed by Astellas and Kotobuki Pharmaceutical (Kotobuki). The company said that SGLTs are membrane proteins that
DCR-MYC is a Dicer Substrate siRNA (DsiRNA) that targets the driver oncogene MYC, which is central to the growth of many hematologic and solid tumor malignancies. The company
The drug being developed is a low cost cure for drug-resistant malaria that is as safe as chloroquine, a frontline drug used for many years until rendered ineffective
The acquisition, which is subject to customary closing conditions, is expected to be completed in the first quarter of fiscal 2015. The deal is expected to double the
OncoExplorer is the latest addition to the RainTree Analytics suite of products. Information Builders’ iWay integration and integrity products have been used by RainTree Oncology Services to implement
PSX1001 and PSX1050 are being developed as generic versions to GlaxoSmithKline’s pressurised metered dose inhalers (pMDI) Flixotide and Flovent, respectively. Flixotide and Flovent contain the active ingredient fluticasone
Rasuvo, which is currently under FDA review, is being developed for multiple indications, including rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis. The drug is designed to improve
The once-weekly treatment of albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), is administered using an injector pen supplied with a 5mm 29-gauge thin-walled needle. GLP-1 is an important
The company said that initial target indication is pain management for patients suffering from oral mucositis during cancer therapy. In several pilot studies, Oracain has produced promising clinical
Launch of Viorra in Mexico is expected later in 2014, subject to the regulatory approvals and finalizing the sourcing out of a suitable manufacturing partner. The company said
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.